Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses

Alexandre Gaymard,Caroline Picard,Guilhem Vazzoler,Pascale Massin,Emilie Frobert,Murielle Sabatier,Mendy Barthelemy,Martine Valette,Michèle Ottmann,Jean-Sébastien Casalegno,Bruno Lina,Vanessa Escuret

DOI: https://doi.org/10.3390/v16030388

2024-03-02

Viruses

Abstract:The H274Y substitution (N2 numbering) in neuraminidase (NA) N1 confers oseltamivir resistance to A(H1N1) influenza viruses. This resistance has been associated with reduced N1 expression using transfected cells, but the effect of this substitution on the enzymatic properties and on the expression of other group-1-NA subtypes is unknown. The aim of the present study was to evaluate the antiviral resistance, enzymatic properties, and expression of wild-type (WT) and H274Y-substituted NA for each group-1-NA. To this end, viruses with WT or H274Y-substituted NA (N1pdm09 or avian N4, N5 or N8) were generated by reverse genetics, and for each reverse-genetic virus, antiviral susceptibility, NA affinity (Km), and maximum velocity (Vm) were measured. The enzymatic properties were coupled with NA quantification on concentrated reverse genetic viruses using mass spectrometry. The H274Y-NA substitution resulted in highly reduced inhibition by oseltamivir and normal inhibition by zanamivir and laninamivir. This resistance was associated with a reduced affinity for MUNANA substrate and a conserved Vm in all viruses. NA quantification was not significantly different between viruses carrying WT or H274Y-N1, N4 or N8, but was lower for viruses carrying H274Y-N5 compared to those carrying a WT-N5. In conclusion, the H274Y-NA substitution of different group-1-NAs systematically reduced their affinity for MUNANA substrate without a significant impact on NA Vm. The impact of the H274Y-NA substitution on viral NA expression was different according to the studied NA.

virology

What problem does this paper attempt to address?

This paper aims to evaluate the effects of the H274Y mutation on antiviral resistance, enzymatic properties and expression of group 1 neuraminidases (N1, N4, N5, and N8) in influenza virus A. Specifically, the researchers generated viruses carrying wild - type (WT) or H274Y - mutant neuraminidases through reverse genetics techniques, and measured the sensitivity of these viruses to antiviral drugs, the affinity (\(K_m\)) and the maximum reaction rate (\(V_m\)) of neuraminidases. Meanwhile, they quantified the neuraminidase expression in concentrated viruses using mass spectrometry. The main objective of the study was to understand how the H274Y mutation affects the function and expression of different types of neuraminidases, especially their expression in virus particles. ### Main findings: 1. **Antiviral resistance**: The H274Y mutation led to high - level resistance (HRI) to oseltamivir in all tested group 1 neuraminidases, while the inhibitory effects on zanamivir and laninamivir remained normal. 2. **Enzymatic properties**: - The H274Y mutation significantly increased the \(K_m\) values of all tested neuraminidases for the MUNANA substrate, indicating that the mutation reduced the enzyme's affinity for the substrate. - There was no significant difference in the \(V_m\) values between WT and H274Y - mutant neuraminidases, indicating that even though the affinity decreased, the maximum reaction rate of the enzyme remained unchanged. 3. **Neuraminidase expression**: Mass spectrometry analysis showed that the H274Y mutation had no significant effect on the expression levels of N1, N4, and N8, but significantly reduced the expression level of N5. ### Conclusion: The H274Y mutation systematically led to high - level resistance to oseltamivir and reduced the affinity of all tested group 1 neuraminidases for the MUNANA substrate, but did not affect the maximum reaction rate of the enzyme. In addition, the H274Y mutation had different effects on the expression of different neuraminidases in virus particles, especially significantly reducing the expression level of N5. This study provides detailed data on the effects of the H274Y mutation on the function and expression of influenza virus neuraminidases, which is helpful for understanding the significance of this mutation in antiviral therapy.

Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses

Functional And Structural Analysis Of Influenza Virus Neuraminidase N3 Offers Further Insight Into The Mechanisms Of Oseltamivir Resistance

Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affect NA Enzyme Activity, Hemagglutination Titer, Mouse Virulence, and Inactivated-Virus Immunogenicity

Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo .

Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Insights into Susceptibility of Antiviral Drugs Against the E119G Mutant of 2009 Influenza A (H1N1) Neuraminidase by Molecular Dynamics Simulations and Free Energy Calculations.

Characterization of Neuraminidases from the Highly Pathogenic Avian H5N1 and 2009 Pandemic H1N1 Influenza A Viruses

Molecular modeling and phylogenetic analyses highlight the role of amino acid 347 of the N1 subtype neuraminidase in influenza virus host range and interspecies adaptation

Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants

Theoretical Studies on the Susceptibility of Oseltamivir Against Variants of 2009 A/H1N1 Influenza Neuraminidase.

Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French multicenter observational cohort study.

Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases

Increase of permissive secondary antiviral mutations in the evolution of A(H1N1)pdm09 influenza virus neuraminidases

Structural and Functional Analysis of Laninamivir and Its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition.

Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus

R229I substitution from oseltamivir induction in HA1 region significantly increased the fitness of a H7N9 virus bearing NA 292K

Optimization of N-Substituted Oseltamivir Derivatives As Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Characterization of Viral Genomic Mutations in Novel Influenza A (H7n9)-Infected Patients: the Association Between Oseltamivir-Resistant Variants and Viral Shedding Duration

Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China

Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors

Effect of the fourth nucleotide at the 3' end of neuraminidase and matrix viral genomic RNA on the pathogenicity of influenza virus A/PR/8/34